APA (7th ed.) Citation

Aisner, D. L. (2018). The Impact of Smoking and TP53 Mutations in Lung Adenocarcinoma Patients with Targetable Mutations--The Lung Cancer Mutation Consortium (LCMC2). The American Association for Cancer Research (AACR).

Chicago Style (17th ed.) Citation

Aisner, D. L. The Impact of Smoking and TP53 Mutations in Lung Adenocarcinoma Patients with Targetable Mutations--The Lung Cancer Mutation Consortium (LCMC2). The American Association for Cancer Research (AACR), 2018.

MLA (9th ed.) Citation

Aisner, D. L. The Impact of Smoking and TP53 Mutations in Lung Adenocarcinoma Patients with Targetable Mutations--The Lung Cancer Mutation Consortium (LCMC2). The American Association for Cancer Research (AACR), 2018.